Although under physiological conditions α-synuclein plays a role in the regulation of neurotransmitters’ release, its overexpression and aggregation lead to toxic effects which are involved in the pathogenesis of PD, and thus suppression of these events is thought to be a potential strategy to manage the disease [91]. This evidence concerns the gene SNCA and Parkinson disease.